10.01.2011 • News

Euticals to Acquire Archimica Group

The Italian pharma fine chemicals company Euticals will buy Archimica from TowerBrook Capital Parners for an undisclosed sum. Completion of the transaction is expected in early February.

TowerBrook acquired Archimica, a player in the pharmaceutical fine chemicals industry, in June 2006. The company has approximately 550 employees at six production sites in Italy, France, Germany, US and UK and achieved strong sales of €131 million in 2009, a 16% increase from 2008.

Euticals Group is a successful pharmaceuticals fine chemicals company with sales in 2010 of €93 million and five production sites near Milan, Italy. Euticals and Archimica said they expect the combination to be strategic, creating new opportunities to further develop business activities in the fine chemicals sector.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.